The 12th Five Year Plan (2011-2015) for the biopharmaceutical industry may have over 10 billion RMB ($1.5 billion) in development support for new drugs. The plan is in final draft form and may be announced in late August, according to unnamed sources that were quoted by the 21st Century Business Herald. More details...